RA CAPITAL MANAGEMENT, L.P. purchased 3.69M shares of SPYGLASS PHARMA, INC. on the open market
Open‑market purchase worth $59.04M. The strongest form of insider conviction signal.
Common Stock
Shares
+2.52M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.81M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+3.44M
Price / share
$16.00
Trade value
$55.07M
% of position
Common Stock
Shares
+248.03K
Price / share
$16.00
Trade value
$3.97M
% of position
Net shares
+8.02M
Net value
$59.04M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/9/2026 | C · Conversion | +2.52M | — | — | New position | 0.00 | 2.52M |
| Common Stock Indirect | 2/9/2026 | C · Conversion | +1.81M | — | — | New position | 0.00 | 1.81M |
| Common Stock Indirect | 2/9/2026 | P · Purchase | +3.44M | $16.00 | $55.07M | 136.3% | 2.52M | 5.97M |
| Common Stock Indirect | 2/9/2026 | P · Purchase | +248.03K | $16.00 | $3.97M | 13.7% | 1.81M | 2.05M |
| Total | +8.02M | $59.04M | ||||||
Series C-1 Preferred Stock
Common Stock
1.15M shares
Shares
−1.15M
Strike price
Held after
0.00
Exercisable
—
Series C-1 Preferred Stock
Common Stock
767.29K shares
Shares
−767.29K
Strike price
Held after
0.00
Exercisable
—
Series C-2 Preferred Stock
Common Stock
1.15M shares
Shares
−1.15M
Strike price
Held after
0.00
Exercisable
—
Series C-2 Preferred Stock
Common Stock
767.29K shares
Shares
−767.29K
Strike price
Held after
0.00
Exercisable
—
Series D Preferred Stock
Common Stock
222.59K shares
Shares
−222.59K
Strike price
Held after
0.00
Exercisable
—
Series D Preferred Stock
Common Stock
272.06K shares
Shares
−272.06K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C-1 Preferred Stock Indirect | Common Stock1.15M shares | 2/9/2026 | C · Conversion | −1.15M | — | 0.00 | |
| Series C-1 Preferred Stock Indirect | Common Stock767.29K shares | 2/9/2026 | C · Conversion | −767.29K | — | 0.00 | |
| Series C-2 Preferred Stock Indirect | Common Stock1.15M shares | 2/9/2026 | C · Conversion | −1.15M | — | 0.00 | |
| Series C-2 Preferred Stock Indirect | Common Stock767.29K shares | 2/9/2026 | C · Conversion | −767.29K | — | 0.00 | |
| Series D Preferred Stock Indirect | Common Stock222.59K shares | 2/9/2026 | C · Conversion | −222.59K | — | 0.00 | |
| Series D Preferred Stock Indirect | Common Stock272.06K shares | 2/9/2026 | C · Conversion | −272.06K | — | 0.00 |